BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12411152)

  • 1. Regulative effect of IFN-gamma on the Fas/Fas L system of cholangiocarcinoma cells.
    Li Z; Wang J; Tang C; Wang X; Zou S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):495-8. PubMed ID: 12411152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas counterattack in cholangiocarcinoma: a mechanism for immune evasion in human hilar cholangiocarcinomas.
    Li ZY; Zou SQ
    World J Gastroenterol; 2001 Dec; 7(6):860-3. PubMed ID: 11854917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).
    Vickers SM; Jhala NC; Ahn EY; McDonald JM; Pan G; Bland KI
    Ann Surg; 2002 Jun; 235(6):872-8. PubMed ID: 12035045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The "Fas counterattack": a mechanism for immune evasion in human hilar cholangiocarcinomas].
    Li Z; Zhang L; Zou S
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):606-9. PubMed ID: 12133481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma.
    Ahn EY; Pan G; Vickers SM; McDonald JM
    Int J Cancer; 2002 Aug; 100(4):445-51. PubMed ID: 12115528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
    Pan G; Ahn EY; Chen Y; Feng G; Reddy V; Jhala NC; McDonald JM
    Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.
    Carnevale G; Carpino G; Cardinale V; Pisciotta A; Riccio M; Bertoni L; Gibellini L; De Biasi S; Nevi L; Costantini D; Overi D; Cossarizza A; de Pol A; Gaudio E; Alvaro D
    Sci Rep; 2017 Oct; 7(1):14419. PubMed ID: 29089545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus expressing p27KIP1 induces apoptosis against cholangiocarcinoma cells by triggering Fas ligand on the cell surface.
    Yamamoto K; Katayose Y; Suzuki M; Unno M; Sasaki T; Mizuma M; Shiraso S; Ohtuka H; Cowan KH; Seth P; Matsuno S
    Hepatogastroenterology; 2003; 50(54):1847-53. PubMed ID: 14696417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanism of γ-aminobutyric acid inhibitory on the growth of cholangiocarcinoma QBC939 cell line].
    Zhu CL; Huang Q; Liu CH; Xie F; Zhu K
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):261-5. PubMed ID: 23859331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
    Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
    Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of Fas, FasL and IFN-gamma in gastric cancer].
    Li Z; Wang Z; Zhao Z; Zhang Y; Ke Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):386-9. PubMed ID: 12947554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
    Afford SC; Ahmed-Choudhury J; Randhawa S; Russell C; Youster J; Crosby HA; Eliopoulos A; Hubscher SG; Young LS; Adams DH
    FASEB J; 2001 Nov; 15(13):2345-54. PubMed ID: 11689460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-γ affects leukemia cell apoptosis through regulating Fas/FasL signaling pathway.
    Xia HL; Li CJ; Hou XF; Zhang H; Wu ZH; Wang J
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2244-2248. PubMed ID: 28537657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL.
    Spanaus KS; Schlapbach R; Fontana A
    Eur J Immunol; 1998 Dec; 28(12):4398-408. PubMed ID: 9862377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
    Kaser A; Nagata S; Tilg H
    Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of immune escape in renal cell carcinoma].
    Zheng J; Sun X; Chen J; Jiang F; Li W; Xie S
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):24-6. PubMed ID: 11977630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.
    Nzeako UC; Guicciardi ME; Yoon JH; Bronk SF; Gores GJ
    Hepatology; 2002 Mar; 35(3):552-9. PubMed ID: 11870367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fas (FasB) regulates luteal cell apoptosis during luteolysis in murine ovaries.
    Komatsu K; Manabe N; Kiso M; Shimabe M; Miyamoto H
    Mol Reprod Dev; 2003 Aug; 65(4):345-52. PubMed ID: 12840807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.